Goldline Pharmaceutical logo

Goldline Pharmaceutical IPO Review

Goldline Pharmaceutical IPO Pages

Goldline Pharmaceutical IPO Goldline Pharmaceutical IPO GMP Goldline Pharmaceutical Subscription Status Goldline Pharmaceutical Allotment Status Goldline Pharmaceutical IPO Review
📝

Detailed review coming soon

Our editorial team is preparing an in-depth analysis of Goldline Pharmaceutical IPO covering company financials, valuation, strengths, risks and apply-or-skip verdict. Below is the structured information we have confirmed so far.

Price / Issue Price
₹43
Lot Size
3000
Type
Sme
Exchange
BSE SME
Sector
Healthcare & Pharma
View official prospectus →
Already listed. Issued at ₹43, listed at ₹59 (+38.95%) on 18 May 2026.

IPO Details

Type
Sme
Country
India
Sector
Healthcare & Pharma

Related IPOs